OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Pathogenesis of autoimmune disease
David S. Pisetsky
Nature Reviews Nephrology (2023) Vol. 19, Iss. 8, pp. 509-524
Open Access | Times Cited: 270

Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes
Maria Fasolino, Gregory W. Schwartz, Abhijeet R. Patil, et al.
Nature Metabolism (2022) Vol. 4, Iss. 2, pp. 284-299
Open Access | Times Cited: 104

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Nathaniel J. Hogrebe, Matthew Ishahak, Jeffrey R. Millman
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 530-548
Open Access | Times Cited: 89

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Motahareh Arjomandnejad, Acadia L. Kopec, Allison M. Keeler
Biomedicines (2022) Vol. 10, Iss. 2, pp. 287-287
Open Access | Times Cited: 71

Heterogeneity and endotypes in type 1 diabetes mellitus
María J. Redondo, Noel G. Morgan
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 542-554
Closed Access | Times Cited: 65

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
Mark A. Atkinson, Raghavendra G. Mirmira
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1500-1518
Open Access | Times Cited: 49

Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 34

CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3

The Human Islet: Mini-Organ With Mega-Impact
John T. Walker, Diane C. Saunders, Marcela Briššová, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 605-657
Open Access | Times Cited: 67

Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment
Qingxia Lin, Kezheng Li, Yinuo Chen, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4574-4594
Closed Access | Times Cited: 37

Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis
Jeayoung Park, Spyridon Ntelis, Elvina Yunasan, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. 279-292
Open Access | Times Cited: 31

How inflammation dictates diabetic peripheral neuropathy: An enlightening review
Yifan Cheng, Yinuo Chen, Kezheng Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 25

Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age‐period‐cohort analysis of China and global mortality burden from 1990 to 2019
Chunping Dong, Guifu Wu, Hui Li, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 623-633
Open Access | Times Cited: 13

Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity
Matthew C. Austin, Charanya Muralidharan, Saptarshi Roy, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1

Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice
Sarah K. Popp, Federica Vecchio, Debra Brown, et al.
JCI Insight (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 31

Loss of β-cell identity and dedifferentiation, not an irreversible process?
Sumit Patel, Marı́a S. Remedi
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6

Investigating the Interplay: Periodontal Disease and Type 1 Diabetes Mellitus—A Comprehensive Review of Clinical Studies
Stefania Vlachou, Alexandre Loumé, Catherine Giannopoulou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7299-7299
Open Access | Times Cited: 6

NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
Liang‐Jun Yan
Biomolecules (2021) Vol. 11, Iss. 5, pp. 730-730
Open Access | Times Cited: 36

The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes
Alessandra Petrelli, Sarah K. Popp, Riho Fukuda, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22

CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes
Ting Zhong, Xinyu Li, Kang Lei, et al.
Journal of Autoimmunity (2024) Vol. 143, pp. 103171-103171
Closed Access | Times Cited: 4

AnnoSpat annotates cell types and quantifies cellular arrangements from spatial proteomics
Aanchal Mongia, Fatema Tuz Zohora, Noah G. Burget, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Regulation and function of insulin and insulin-like growth factor receptor signalling
Eunhee Choi, Cunming Duan, Xiao‐chen Bai
Nature Reviews Molecular Cell Biology (2025)
Closed Access

Pharmacotherapy of type 1 diabetes - part 2 Today
Marc Rendell
Expert Opinion on Pharmacotherapy (2025)
Closed Access

Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression
Verena van der Heide, Sara McArdle, Michael S. Nelson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Page 1 - Next Page

Scroll to top